Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Preventing brain atrophy should be the gold standard of effective therapy in multiple sclerosis (after the first year of treatment): Commentary.
Autologous hematopoietic stem cell transplantation for multiple sclerosis - if confused or hesitant, remember: 'Treat with standard immune suppressive drugs and if no inflammation, no response'.
TCR Bias and HLA Cross-Restriction Are Strategies of Human Brain-Infiltrating JC Virus-Specific CD4+ T Cells during Viral Infection.
Vitamin B(12) in neurology and ageing; Clinical and genetic aspects.
Health-related quality of life and economic impact of urinary incontinence due to detrusor overactivity associated with a neurologic condition: a systematic review.
Cerebrospinal fluid and urinary biomarkers in multiple sclerosis.
CD226 Gly307Ser association with multiple autoimmune diseases: A meta-analysis.
The Prevalence of the Classical and non-Classical Cardiovascular Risk Factors in Multiple Sclerosis Patients.
[Review on domestic published papers regarding the acute disseminated encephalomyelitis and its relations with rabies vaccination].
Myelin repair and functional recovery mediated by neural cell transplantation in a mouse model of multiple sclerosis.
[The quality of nighttime sleep in patients with multiple sclerosis].
Selective inhibition by riluzole of voltage-dependent sodium channels and catecholamine secretion in adrenal chromaffin cells.
Estimating typical multiple sclerosis disability progression speed from clinical observations.
Vowel Acoustics in Parkinson's disease and Multiple Sclerosis: Comparison of Clear, Loud and Slow Speaking Conditions.
Demyelination and other neurological adverse events after anti-TNF therapy.
Interleukin-10 expression during the acute phase is a putative prerequisite for delayed viral elimination in a murine model for multiple sclerosis.
Immunomodulatory synergy by combining atorvastatin and rapamycin in the treatment of experimental autoimmune encephalomyelitis (EAE).
Opioid growth factor arrests the progression of clinical disease and spinal cord pathology in established experimental autoimmune encephalomyelitis.
Walking speed, rather than Expanded Disability Status Scale, relates to long-term patient-reported impact in progressive MS.
Personalized medicine in multiple sclerosis: hope or reality?
Induction chemotherapy, extrapleural pneumonectomy, and adjuvant radiotherapy for malignant pleural mesothelioma: experience of Guy's and St Thomas' hospitals.
The Impact of Interferon Beta and Natalizumab on Comorbid Migraine in Multiple Sclerosis.
Subject movement during multislice interleaved MR acquisitions: Prevalence and potential effect on MRI-derived brain pathology measurements and multicenter clinical trials of therapeutics for multiple sclerosis.
The potential of mesenchymal stromal cells as a novel cellular therapy for multiple sclerosis.
Central nervous system demyelinating disease-associated uveitis.

Pages